marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Sensei Biotherapeutics Bilanz 2011-2024 | SNSE
Bilanz Jährlich Sensei Biotherapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-10.7 M | -15 M | -5.48 M | -15.5 M | 15.8 M | 4.09 M | - | - | - | - | - | - | - |
Langfristige Schulden |
768 K | 1.58 M | 1.67 M | 567 K | - | 4.05 M | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.57 M | 1.25 M | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 73 M | 48.2 M | 52.7 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
5.64 M | 9.07 M | 4.89 M | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
9.48 M | 15 M | 6.71 M | 77.9 M | 69.9 M | 55.3 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-232 M | -198 M | -149 M | -112 M | -92.3 M | -75.6 M | - | - | - | - | - | - | - |
Vermögenswerte |
74.4 M | 118 M | 153 M | 21.4 M | 1.22 M | 1.85 M | - | - | - | - | - | - | - |
Zahlungsmittel |
13 M | 17.8 M | 7.16 M | - | - | - | - | - | - | - | - | - | - |
Buchwert |
64.9 M | 103 M | 147 M | -56.4 M | -68.7 M | -53.5 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
64.9 M | 103 M | 147 M | -56.4 M | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Sensei Biotherapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
206 K | 377 K | 571 K | 768 K | 962 K | 1.16 M | 1.35 M | 1.58 M | 1.68 M | 1.72 M | 1.85 M | 1.67 M | - | 567 K | 567 K | 567 K | 567 K | 567 K | 567 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
7.48 M | 7.61 M | 8.22 M | 9.48 M | 10.7 M | 10.4 M | 13.1 M | 15 M | 14.8 M | 12.1 M | 14.7 M | 6.71 M | 6.04 M | 4.6 M | 3.22 M | 5.54 M | 5.54 M | 5.54 M | 5.54 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-254 M | -247 M | -240 M | -232 M | -224 M | -217 M | -208 M | -198 M | -186 M | -172 M | -162 M | -149 M | -140 M | -130 M | -120 M | -112 M | -112 M | -112 M | -112 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
53.3 M | 59.8 M | 66.7 M | 74.4 M | 81.7 M | 89.6 M | 108 M | 118 M | 129 M | 138 M | 150 M | 153 M | 161 M | 168 M | 174 M | 21.4 M | 21.4 M | 21.4 M | 21.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
19.1 M | 11.9 M | 11 M | 13 M | 11.3 M | 10.2 M | 8.11 M | 17.8 M | 11.4 M | 9.9 M | 8.72 M | 7.16 M | 9.53 M | 15.6 M | 169 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
45.8 M | 52.2 M | 58.5 M | 64.9 M | 71 M | 79.2 M | 94.8 M | 103 M | 114 M | 126 M | 135 M | 147 M | 155 M | 163 M | 171 M | 15.9 M | 15.9 M | 15.9 M | 15.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
45.8 M | 52.2 M | 58.5 M | 64.9 M | 71 M | 79.2 M | 94.8 M | 103 M | 114 M | 126 M | 135 M | 147 M | 155 M | 163 M | 171 M | -56.4 M | -56.4 M | -56.4 M | -56.4 M | -68.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung